Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Cumberland Pharmaceuticals clinical trials
The registry lists 49 studies whose lead sponsor is Cumberland Pharmaceuticals. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 2, 2026.
Keep track of what changes. Save the Cumberland Pharmaceuticals studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Cumberland Pharmaceuticals.
- Cumberland Pharmaceuticals49 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 49 of 49.
- Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT05571059Phase 2
- Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionActive, not recruitingNCT02682511Phase 2
- Oral Ifetroban in Subjects With Duchenne Muscular DystrophyCompletedNCT03340675Phase 2
- Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)CompletedNCT03028350Phase 2
- Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)TerminatedNCT02013141Phase 1
- Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous IbuprofenCompletedNCT01334957Phase 4
- Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous IbuprofenCompletedNCT01334944Phase 4
- Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic PatientsCompletedNCT03611010Phase 2
- Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic PatientsCompletedNCT02802228Phase 2
- Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric PatientsCompletedNCT02583399Phase 4
- VIBATIV Pregnancy RegistryWithdrawnNCT01130324
- A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia TrialTerminatedNCT02208063Phase 3
- Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusCompletedNCT00124020Phase 3
- Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusCompletedNCT00091819Phase 3
- Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)CompletedNCT00077675Phase 2
- Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusCompletedNCT00107952Phase 3
- Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)CompletedNCT00061633Phase 2
- Telavancin for Treatment of Uncomplicated Staphylococcus Aureus BacteremiaCompletedNCT00062647Phase 2
- Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusCompletedNCT00107978Phase 3
- A Study to Evaluate the Effect of Renal Function on the Biological Activity of TelavancinCompletedNCT01238796Phase 1
- Telavancin Observational Use Registry (TOUR)CompletedNCT02288234
- Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory DiseaseCompletedNCT02216357Phase 2
- Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome PatientsCompletedNCT01436500Phase 2
- Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric PatientsCompletedNCT01002573Phase 3
- Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing TonsillectomyCompletedNCT01332253Phase 3
- A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee SurgeryCompletedNCT01650519Phase 4
- Trial of Caldolor for Treatment of Pain in Post-Operative Adult PatientsCompletedNCT00225732Phase 3
- Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee SurgeryCompletedNCT01901393Phase 4
- A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic HyponatremiaTerminatedNCT01451411Phase 3
- Efficacy and Safety of Bisacodyl and Lactulose as a Preparation for ColonoscopyCompletedNCT02123017Phase 2
- Efficacy and Safety Study of Caldolor (IV Ibuprofen) in Hospitalized Adult Orthopedic PatientsCompletedNCT00470600Phase 3
- 2 Regimens of Lactulose for Colonoscopy Preparation in AdultsCompletedNCT01887470Phase 2
- Pharmacokinetic Study Of Ibuprofen Injection (IVIb) In Healthy Adult SubjectsCompletedNCT00867880Phase 1
- Safety and Efficacy Study of a New Formulation of Acetylcysteine InjectionTerminatedNCT01118663Phase 3
- A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00435591Phase 4
- Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00478192Phase 3
- Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF)TerminatedNCT00843986Phase 3
- A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic PatientsCompletedNCT00592475Phase 2
- Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver FunctionCompletedNCT00851227Phase 1
- Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney FunctionCompletedNCT00887627Phase 1
- A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous ConivaptanCompletedNCT01370148Phase 1
- Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00380575Phase 3
- Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00492037Phase 3
- Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart FailureCompletedNCT00057356Phase 2
- An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00379847Phase 3
- A Preference Study Comparing Kristalose® and Liquid LactuloseCompletedNCT00712543Phase 4
- Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn PatientsCompletedNCT00606489Phase 3
- Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile PatientsCompletedNCT01131000Phase 3
- A Study of Caldolor in Hospitalized Febrile Pediatric PatientsCompletedNCT00225706Phase 3